Publications by authors named "Grazyna Bober"

Claim this Profile
H
High Level of CD8PD-1 Cells in Patients with Chronic Myeloid Leukemia Who Experienced Loss of MMR after Imatinib Discontinuation.
Paulina Kwaśnik, Joanna Zaleska, Dorota Link-Lenczowska, Magdalena Zawada, Hubert Wysogląd, Grażyna Bober

Cells· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib.
Katerina Machova Polakova, Ali Albeer, Vaclava Polivkova, Monika Krutska, Katerina Vlcanova, Grażyna Bober

Leukemia· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Outcomes of Ponatinib Therapy in Patients With Chronic Myeloid Leukemia Resistant or Intolerant to Previous Tyrosine Kinase Inhibitors, Treated in Poland Within the Donation Program.
Tomasz Sacha, Elżbieta Szczepanek, Paulina Dumnicka, Joanna Góra-Tybor, Joanna Niesiobędzka-Krężel, Grażyna Bober

Clin Lymphoma Myeloma Leuk· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical chronic myeloid leukaemia: A case of an orphan disease-A multicenter report by the Polish Adult Leukemia Group.
Joanna Drozd-Sokołowska, Krzysztof Mądry, Anna Waszczuk-Gajda, Przemysław Biecek, Paweł Szwedyk, Grażyna Bober

Hematol Oncol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter prospective study on efficacy and safety of imatinib generics: A report from Polish Adult Leukemia Group imatinib generics registry.
Tomasz Sacha, Joanna Góra-Tybor, Monika Szarejko, Grażyna Bober, Olga Grzybowska-Izydorczyk

Am J Hematol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ear involvement in acute promyelocytic leukemia.
Grzegorz Helbig, Anna Koclęga, Robert Liwoch, Katarzyna Wiśniewski-Piąty, Grażyna Bober

Pol Arch Intern Med· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life and Adherence to Therapy in Patients With Chronic Myeloid Leukemia Treated With Nilotinib as a Second-Line Therapy: A Multicenter Prospective Observational Study.
Tomasz Sacha, Joanna Góra-Tybor, Ewa Wąsak-Szulkowska, Sławomira Kyrcz-Krzemień, Ewa Mędraś, Grażyna Bober

Clin Lymphoma Myeloma Leuk· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occurrence of secondary malignancies in chronic myeloid leukemia during therapy with imatinib mesylate-single institution experience.
Grzegorz Helbig, Grażyna Bober, Marek Seweryn, Ryszard Wichary, Andrzej Tukiendorf

Mediterr J Hematol Infect Dis· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for JAK2 V617F point mutation in patients with hypereosinophilic syndrome-in response to 'Hypereosinophilic syndrome: another face of janus?' by Dahabreh et al. published in Leukemia Research, in press.
Grzegorz Helbig, Mirosław Majewski, Agata Wieczorkiewicz, Grazyna Bober, Janina Grzegorczyk

Leuk Res· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The achievement of complete molecular remission after autologous stem cell transplantation for T-cell lymphoma with associated hypereosinophilia, rare aberration t(6;11) and elevated IL-4 and IgE.
Grzegorz Helbig, Beata Stella-Holowiecka, Grazyna Bober, Miroslaw Majewski, Janina Grzegorczyk

Haematologica· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The results of imatinib therapy for patients with primary eosinophilic disorders.
Grzegorz Helbig, Beata Stella-Holowiecka, Sebastian Grosicki, Grazyna Bober, Magorzata Krawczyk

Eur J Haematol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A study to determine the safety and efficacy of imatinib mesylate in patients with chronic phase of chronic myeloid leukemia after interferon therapy failure. Four year follow-up].
Jerzy Hołowiecki, Lech Konopka, Grazyna Bober, Sebastian Giebel, Bernadeta Ceglarek

Pol Arch Med Wewn· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Severe thrombocytopenia associated with simultaneous cytomegalovirus and Epstein-barr virus infection in an immunocompetence patient].
Grazyna Bober, Małgorzata Krawczyk-Kuliś, Małgorzata Kopera, Jerzy Hołowiecki

Pol Arch Med Wewn· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis